Skip to main content
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
letter
. 2020 Jun 18;51(6):600–602. doi: 10.1016/j.arcmed.2020.06.010

Mapping the Changes on Incidence, Case Fatality Rates and Recovery Proportion of COVID-19 in Afghanistan Using Geographical Information Systems

Sayed Hamid Mousavi 1,2, Shafi Ullah Zahid 3, Kalimullah Wardak 4, Kazim Ali Azimi 5,6, Sayed Mohammad Reza Hosseini 7, Marzia Wafaee 8, Kuldeep Dhama 9, Ranjit Sah 10, Ali A Rabaan 11, Kovy Arteaga-Livias 12,13, D Katterine Bonilla-Aldana 14,15, Alfonso J Rodriguez-Morales 16,17,18,
PMCID: PMC7301143  PMID: 32620302

To the editor,

We read with great interest the article by Pradhan et al., about the current interventions for the Coronavirus Disease 2019 (COVID-19) prevention (1), discussing different strategies to be applied at individuals for avoiding the Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission. We would like to compliment and discuss the importance of prevention and public health of the use of geographical information systems (GIS)-based mapping, recently applied in other few countries (2,3), now in this analysis, for Afghanistan. Even more, Afghanistan is a country where few studies have been so far published (4, 5, 6). For these reasons, we have developed epidemiological maps of the incidence rates using official populations, by provinces, as well for case fatality rates (CFR%), mortality rates, and the proportion of patients recovered, from COVID-19 in Afghanistan using GIS.

Surveillance cases, deaths and recovery data of the cumulative number of April 26 and May 3, 2020, officially reported by the Afghanistan health authorities were used to estimate the cumulated incidence rates, mortality rates, CFR% and recovery rate (%) on those dates using reference population data on SARS-CoV-2 RT-PCR confirmed infections (cases/100,000 pop) and to develop the maps by provinces, using the GIS software Kosmo® 3.1. Starting on February 24, 2020, the first cases of SARS-CoV-2 was confirmed in a 35 year old man (3). He was part of a group of three returning travelers at Herat, who had recently come from Qom, Iran, suspected of COVID-19 infection (5). On March 22, 2020, the government took the lockdown measure for the city of Herat. Four days later extended the lockdown to Kabul, Kandahar, and Logar provinces.

Up to April 26, 2020, after 62 d of epidemics, 1,463 cases of COVID-19 were reported in the country, for a cumulated rate of 4.76 cases/100,000 population, reaching 2,706 cases during May 3, 2020, for a rate of 8.81. All the provinces of the country have been affected except Nurestan (Nuristan), with rates ranging from 0.2 (Badakhshan) to 28.9 cases/100,000 population (Nemroz/Nimroz) (Figure 1 ). At Herat (Hirat), where the first case was reported for May 3, 2020, 541 cases were confirmed with 25.8 an incidence rate of cases/100,000 population. The highest number of cases have been reported in Kabul, the capital, 755, with a rate of 15.0 cases/100,000 population (Figure 1). From April 26–May 3, in addition to Nimroz, two additional provinces reached an incidence higher than 25 cases/100,000 population, Hirat, and Kandahar (Figure 1). From the total number of cases up to May 3, 2020, 85 died (3.1%), but that CFR% ranged at provinces from 0–50% (Jowzjan and Paktika) in the two time-point measured (Figure 1), yielding a cumulative mortality rate of 0.28 deaths/100,000 population at the national level, ranging at provinces from 0–0.88 deaths/100,000 population (Balkh) (Figure 1). Finally, 345 cases have recovered (12.7%), also ranging in provinces from 0–55% for May 3, 2020 (Figure 1). Maps showed that while southwestern provinces have a higher incidence, the fatality and mortality rates seem higher in northeastern provinces (Figure 1).

Figure 1.

Figure 1

Key points related to the current technological advances on emerging approaches to improve control and particularly diagnosis of the SARS-CoV-2/COVID-19 pandemic.

Afghanistan cases originated from a neighbor country, Iran, which currently is in the top ten of countries globally regarding COVID-19 cases (207,525) (June 22, 2020) (5). At the same time, that contrast highly with another border country, Turkmenistan, which has no reported cases yet (Figure 1). But the government has worked to control information about the virus, and experts suspect that it may be spreading in the country unreported.

Given the current findings, population-based interventions should be targeted, especially in those high-risk areas for occurrence and fatalities. In Afghanistan, health care delivery is already a major cross-cutting challenge. Although efforts to rebuild the health care systems in Afghanistan have been made, both acute and chronic illnesses remain as significant medical and critical governance gaps to be remedied. Besides, health care facilities and medical equipment are not adequate in the country. There is a need for medical and scientific expertise to clinically and sociologically contextualize and interpret diagnostic tests as well as drugs and vaccines that will be deployed in the coming months as part of the planetary collective response to the COVID-19 pandemic (6).

Besides, specific studies in vulnerable populations such as those displaced by conflicts and people affected by natural disasters should be performed. Afghanistan is still endemic for many emerging infectious diseases such as poliomyelitis and measles (7). Because of inadequate health-care services in Afghanistan, many ill people will try to seek medical care overseas. At the same time, broad travel restrictions and flight suspensions come into force in the country.

Funding

None.

Conflicts of Interest

None.

(ARCMED_2020_666)

Supplementary data

Data Profile
mmc1.xml (203B, xml)

References

  • 1.Pradhan D., Biswasroy P., Kumar naik P. A review of current interventions for COVID-19 prevention. Arch Med Res. 2020;51:363–374. doi: 10.1016/j.arcmed.2020.04.020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Arab-Mazar Z., Sah R., Rabaan A.A. Mapping the incidence of the COVID-19 hotspot in Iran - Implications for Travellers. Travel Med Infect Dis. 2020;34:101630. doi: 10.1016/j.tmaid.2020.101630. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Mollalo A., Vahedi B., Rivera K.M. GIS-based spatial modeling of COVID-19 incidence rate in the continental United States. Sci Total Environ. 2020;728:138884. doi: 10.1016/j.scitotenv.2020.138884. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Shah J., Karimzadeh S., Al-Ahdal T.M.A. COVID-19: the current situation in Afghanistan. Lancet Glob Health. 2020;8:e771–e772. doi: 10.1016/S2214-109X(20)30124-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Mousavi S.H., Shah J., Giang H.T.N. The first COVID-19 case in Afghanistan acquired from Iran. Lancet Infect Dis. 2020;20:657–658. doi: 10.1016/S1473-3099(20)30231-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Azizy A., Fayaz M., Agirbasli M. Do not forget afghanistan in times of COVID-19: telemedicine and the internet of things to strengthen planetary health systems. OMICS. 2020;24:311–313. doi: 10.1089/omi.2020.0053. [DOI] [PubMed] [Google Scholar]
  • 7.Franco-Paredes C., Santos-Preciado J.I., Henao-Martinez A.F. Preventing paralytic polio caused by vaccine-derived poliovirus type 2. Lancet Infect Dis. 2020;20:21–22. doi: 10.1016/S1473-3099(19)30692-9. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Data Profile
mmc1.xml (203B, xml)

Articles from Archives of Medical Research are provided here courtesy of Elsevier

RESOURCES